Abstract:Introduction. The treatment outcome of adolescents and young adults with
acute lymphoblastic leukemia is much poorer in contrast to pediatric
patients. By changing the concept of the treatment for patients who are
adolescents and young adults with acute lymphoblastic leukemia, especially
with the use of pediatric regimens, significant improvement in survival has
been made (current 5-year survival rate goes up to 70%). Contributing
factors for different outcomes between children and adolescent… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.